SB
Insider
Sean Brynjelsen
President & CEOSean Brynjelsen (President & CEO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Eton Pharmaceuticals, Inc. (ETON). The largest single filing was $6.1M of ETON (100,000 sh across 4 lots, as filed), executed Aug 19.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$9.9M
shares × price, as filed
Last traded
Aug 20
Filed Aug 20
Median ADV $33.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $13.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
ETONRecent filings
ETONSALE
Eton Pharmaceuticals, Inc.
View filing →
$6.1M100,000 sh across 4 lots
Exec Aug 19
Filed Aug 20 · 6:26 PM ET ETONSALE Eton Pharmaceuticals, Inc. View filing → $3.8M
119,852 sh × $31.88
Exec May 28
Filed May 29 · 5:30 PM ET ETONSALE Eton Pharmaceuticals, Inc. View filing → $3.6M
209,600 sh across 4 lots
Exec Jun 3 2025
Filed Jun 5 2025 · 5:30 PM ET